Application of Multifunctional Nanomaterials in Radioprotection of Healthy Tissues

Advanced Healthcare Materials
Jiani XieYuliang Zhao

Abstract

Radiotherapy has been extensively used in clinic for malignant tumors treatment. However, a severe challenge of it is that the ionizing radiation needed to kill tumors inevitably causes damage to surrounding normal tissues. Although some of the molecular radioprotective drugs, such as amifostine, have been used as clinical adjuvants to radio-protect healthy tissues, their shortcomings such as short systemic circulation time and fast biological clearing from the body largely hinder the sustained bioactivity. Recently, with the rapid development of nanotechnology in the biological field, the multifunctional nanomaterials not only establish powerful drug delivery systems to improve the molecular radioprotective drugs' biological availability, but also open a new route to develop neozoic radioprotective agents because some nanoparticles possess intrinsic radioprotective abilities. Therefore, considering these overwhelming superiorities, this review systematically summarizes the advances in healthy tissue radioprotection applications of multifunctional nanomaterials. Furthermore, this review also points out a perspective of nanomaterial designs for radioprotection applications and discusses the challenges and future outlooks of the ...Continue Reading

References

Jun 8, 2001·Journal of Radiation Research·C K NairT Nomura
May 25, 2002·Drug Development and Industrial Pharmacy·T K MandalI Womack
Jul 16, 2005·International Journal of Radiation Biology·Q ZhaoW Li
Jul 16, 2005·International Journal of Radiation Biology·S PamujulaT K Mandal
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Borbala DarocziAdam P Dicker
Feb 24, 2007·Colloids and Surfaces. B, Biointerfaces·Sanja TrajkovićAleksandar Dordević
Feb 27, 2007·Oncogene·H F Horn, K H Vousden
Jul 3, 2007·The Oncologist·John R KouvarisLampros J Vlahos
Jul 21, 2007·Journal of Radiation Research·Alireza ShiraziMahmoud Ghazi-Khansari
Feb 21, 2008·Journal of Radiation Research·Visnja BogdanovićGordana Bogdanović
Jun 17, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·Takeki HamasakiSanetaka Shirahata
Jul 10, 2008·Nature Biotechnology·Kostas Kostarelos
Nov 19, 2008·International Journal of Radiation Biology·Sarala PamujulaTarun K Mandal
Feb 27, 2009·Journal of the American Chemical Society·Rebecca M Lucente-SchultzJames M Tour
Mar 17, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Jimmie ColonCheryl H Baker
Jun 23, 2009·Free Radical Biology & Medicine·Grigory V AndrievskySergey V Gudkov
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Apr 28, 2010·International Journal of Radiation Oncology, Biology, Physics·Andrew D SchweitzerEkaterina Dadachova
Jun 26, 2010·The Journal of Clinical Investigation·Andrei V Gudkov, Elena A Komarova
Jun 29, 2010·Radiation and Environmental Biophysics·Corey A TheriotHonglu Wu
Aug 25, 2010·Mutation Research·Carl N SprungMichael J McKay
Oct 5, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Isabel NawrothJørgen Kjems
Oct 23, 2010·Advanced Drug Delivery Reviews·Sarbari Acharya, Sanjeeb K Sahoo
Jan 6, 2011·Cancer Biotherapy & Radiopharmaceuticals·Gopakumar Gopinathan Nair, Cherupally Krishnan Krishnan Nair
Jan 18, 2011·The Journal of Pharmacy and Pharmacology·Giuseppe CirilloBernd Büchner
May 5, 2011·Cancer Biotherapy & Radiopharmaceuticals·Dhanya K ChandrasekharanCherupally Krishnan Krishnan Nair
May 5, 2011·Mutation Research·Dhanya K ChandrasekharanCherupally Krishnan Krishnan Nair
Sep 15, 2012·Cancer Biotherapy & Radiopharmaceuticals·Dhanya K Chandrasekharan, Cherupally Krishnan Krishnan Nair
Jan 3, 2013·Journal of Biomedical Materials Research. Part a·Ahmad AmiriHossein Eshghi
Mar 21, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Szilvia AranyCatherine E Ovitt
Mar 21, 2013·Nature Chemistry·Manish ChhowallaHua Zhang
Aug 10, 2013·Cancer Medicine·Ana Patricia OrtizErick Suárez
Dec 19, 2013·Genes & Cancer·Anupama Munshi, Rajagopal Ramesh
Nov 26, 2014·Chemical Reviews·Eun-Kyung LimKwangyeol Lee
Apr 18, 2015·Chemical Society Reviews·Manish ChhowallaHua Zhang
Apr 29, 2015·Chemical Reviews·Pamela T Wong, Seok Ki Choi
Oct 5, 2015·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Manish Adhikari, Rajesh Arora

❮ Previous
Next ❯

Citations

Jul 23, 2019·Advanced Materials·Bowen YangJianlin Shi
Sep 19, 2019·Expert Opinion on Drug Safety·Vijay K Singh, Thomas M Seed
Nov 21, 2019·Mini Reviews in Medicinal Chemistry·Annalise R PfaffNuran Ercal
Jul 2, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·N R PopovaV K Ivanov
Jan 29, 2021·Advanced Healthcare Materials·Jiani XieYuliang Zhao
Feb 12, 2021·Bioconjugate Chemistry·Ruiying ZhaoXiao-Dong Zhang
Dec 22, 2020·Advanced Science·Sandhya ClementEwa M Goldys
Feb 2, 2021·Colloids and Surfaces. B, Biointerfaces·Jiangang XuXiaoyu Mu
Apr 12, 2019·Chemical Reviews·Bowen YangJianlin Shi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.